PolarityTE, Inc. engages in the regenerative medicine and tissue engineering platform. The firm seeks to develop and obtain regulatory approval for technology that will utilize a patient's own tissue substrates for the regeneration of skin, bone, muscle, cartilage, fat, blood vessels and nerves. Its products include SkinTE, OsteoTE, AngioTE, MyoTE, CartTe, AdiposeTE, and NeuralTE. The company was founded in 2004 and is headquartered in Salt Lake City, UT.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry Prepackaged software
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:COOL
CUSIPN/A
Phone385-237-2279
Debt
Debt-to-Equity RatioN/A
Current Ratio12.72
Quick Ratio12.72
Price-To-Earnings
Trailing P/E Ratio-0.65
Forward P/E Ratio-4.51
P/E GrowthN/A
Sales & Book Value
Annual Sales$6.69 million
Price / Sales55.23
Cash FlowN/A
Price / CashN/A
Book Value($17.19) per share
Price / Book-1.01
Profitability
EPS (Most Recent Fiscal Year)($26.67)
Net Income$-130,820,000.00
Net MarginsN/A
Return on EquityN/A
Return on Assets-201.36%
Miscellaneous
Employees33
Outstanding Shares21,320,000
Market Cap$371.95 million
Polarityte (NASDAQ:COOL) Frequently Asked Questions
What is Polarityte's stock symbol?
Polarityte trades on the NASDAQ under the ticker symbol "COOL."
How were Polarityte's earnings last quarter?
Polarityte Inc (NASDAQ:COOL) posted its quarterly earnings results on Wednesday, September, 12th. The company reported ($0.86) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.60) by $0.26. The firm had revenue of $0.42 million for the quarter. View Polarityte's Earnings History.
When is Polarityte's next earnings date?
What price target have analysts set for COOL?
1 Wall Street analysts have issued 1 year target prices for Polarityte's stock. Their forecasts range from $65.00 to $65.00. On average, they expect Polarityte's stock price to reach $65.00 in the next year. This suggests a possible upside of 275.1% from the stock's current price. View Analyst Price Targets for Polarityte.
What is the consensus analysts' recommendation for Polarityte?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Polarityte in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Polarityte.
What are Wall Street analysts saying about Polarityte stock?
Here are some recent quotes from research analysts about Polarityte stock:
- 1. According to Zacks Investment Research, "PolarityTE, Inc. creates regenerative medicine and provides tissue engineering platform. It develops and obtains regulatory approval for technology which utilizes a patient's own tissue substrates for regeneration of skin, bone, muscle, cartilage and nerves. The product pipeline comprises SkinTE, OsteoTE, AngioTE, MyoTE, CarteTE, AdiposeTE and NeuralTE. PolarityTE, Inc., formerly known as Majesco Entertainment Company, is headquatered in Salt lake City, Utah. " (8/27/2018)
- 2. Cantor Fitzgerald analysts commented, "We believe that PolarityTE can revolutionize the field of regenerative medicine. We think SkinTE can achieve over $600 million revenue from the currently built out facility, with perhaps multiples of this number when adding bone, cartilage, heart and muscle products in development. $65/sh price target is derived from the combined risk-adjusted NPV of the future cash flows from the SkinTE product and an enterprise value for the follow-on product lines." (7/25/2018)
Who are some of Polarityte's key competitors?
Some companies that are related to Polarityte include Web.com Group (WEB), Instructure (INST), Cheetah Mobile (CMCM), Cango (CANG), Endurance International Group (EIGI), Benefitfocus (BNFT), QAD (QADA), Secureworks (SCWX), Bandwidth (BAND), CommerceHub (CHUBK), CommerceHub (CHUBA), CommerceHub (CHUBB), QAD Inc. Class B (QADB), NCC Group (NCCGF) and Changyou.Com (CYOU).
Who are Polarityte's key executives?
Polarityte's management team includes the folowing people:
- Denver M. Lough, Chairman, President, Chief Executive Officer & CSO
- Edward Swanson, Chief Operating Officer & Executive Vice President
- Paul Mann, Chief Financial Officer
- Michael W. Neumeister, Chief Medical Officer
- Stephen Milner, Chief Clinical Officer
Has Polarityte been receiving favorable news coverage?
Press coverage about COOL stock has trended somewhat positive recently, according to Accern. The research group rates the sentiment of press coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Polarityte earned a news impact score of 0.18 on Accern's scale. They also assigned press coverage about the company an impact score of 46.57 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the near future. View Recent Headlines for Polarityte.
Who are Polarityte's major shareholders?
Polarityte's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Gilder Gagnon Howe & Co. LLC (4.03%), DSAM Partners London Ltd (3.82%), Opaleye Management Inc. (3.76%), FMR LLC (3.43%), BlackRock Inc. (3.35%) and RTW Investments LP (2.00%). Company insiders that own Polarityte stock include Barry C Honig, Edward Winslow Swanson, Jeffrey Hansen Dyer, John Stetson, Michael Martin Beeghley, Paul Elliot Mann and Peter A Cohen. View Institutional Ownership Trends for Polarityte.
Which institutional investors are selling Polarityte stock?
Which institutional investors are buying Polarityte stock?
COOL stock was purchased by a variety of institutional investors in the last quarter, including DSAM Partners London Ltd, Opaleye Management Inc., FMR LLC, Gilder Gagnon Howe & Co. LLC, BlackRock Inc., RTW Investments LP, Ardsley Advisory Partners and 683 Capital Management LLC. Company insiders that have bought Polarityte stock in the last two years include Barry C Honig, Edward Winslow Swanson, Jeffrey Hansen Dyer, John Stetson, Michael Martin Beeghley, Paul Elliot Mann and Peter A Cohen. View Insider Buying and Selling for Polarityte.
How do I buy shares of Polarityte?
Shares of COOL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Polarityte's stock price today?
One share of COOL stock can currently be purchased for approximately $17.33.
How big of a company is Polarityte?
Polarityte has a market capitalization of $371.95 million and generates $6.69 million in revenue each year. The company earns $-130,820,000.00 in net income (profit) each year or ($26.67) on an earnings per share basis. Polarityte employs 33 workers across the globe.
How can I contact Polarityte?
Polarityte's mailing address is 1960 S 4250 W, SALT LAKE CITY UT, 84104. The company can be reached via phone at 385-237-2279 or via email at [email protected]
MarketBeat Community Rating for Polarityte (NASDAQ COOL)
MarketBeat's community ratings are surveys of what our community members think about Polarityte and other stocks. Vote "Outperform" if you believe COOL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe COOL will underperform the S&P 500 over the long term. You may vote once every thirty days.
